Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...

Full description

Saved in:
Bibliographic Details
Published in:Ecancermedicalscience
Main Authors: Pantziarka, Pan, Bouche, Gauthier, Sukhatme, Vidula, Meheus, Lydie, Rooman, Ilse, Sukhatme, Vikas P
Format: Artigo
Language:Inglês
Published: Cancer Intelligence 2016
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102691/
https://ncbi.nlm.nih.gov/pubmed/27899953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.680
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items